Lyell Immunopharma, Inc. (LYEL)

24.00 +0.99 (+4.30%) USD  |  NASDAQ  |  Feb 27, 16:00
24.98 +0.98 (+4.08%) Pre-Market: 20:00
More

Lyell Immunopharma Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade